Dilong Chen

1.1k total citations
54 papers, 832 citations indexed

About

Dilong Chen is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Dilong Chen has authored 54 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Organic Chemistry. Recurrent topics in Dilong Chen's work include Ginseng Biological Effects and Applications (14 papers), Cancer-related molecular mechanisms research (7 papers) and Quinazolinone synthesis and applications (7 papers). Dilong Chen is often cited by papers focused on Ginseng Biological Effects and Applications (14 papers), Cancer-related molecular mechanisms research (7 papers) and Quinazolinone synthesis and applications (7 papers). Dilong Chen collaborates with scholars based in China, Thailand and United States. Dilong Chen's co-authors include Jianhua Ran, Rong Jiang, Wei Xiong, Xiaopeng Li, Guowei Zuo, Danyang Li, Jing Xia, Jing Li, Yi Chen and Jing Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Inorganic Chemistry.

In The Last Decade

Dilong Chen

51 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilong Chen China 18 497 148 131 89 77 54 832
Mengmeng Wang China 17 507 1.0× 130 0.9× 99 0.8× 77 0.9× 42 0.5× 51 952
An Zhu China 20 379 0.8× 97 0.7× 93 0.7× 112 1.3× 50 0.6× 69 985
Minsun Chang South Korea 17 588 1.2× 160 1.1× 85 0.6× 64 0.7× 59 0.8× 46 965
Atul Rawat India 16 341 0.7× 105 0.7× 64 0.5× 49 0.6× 46 0.6× 33 767
Tung-Yuan Lai Taiwan 18 594 1.2× 132 0.9× 65 0.5× 130 1.5× 104 1.4× 28 983
Siqi Feng China 18 356 0.7× 87 0.6× 90 0.7× 73 0.8× 130 1.7× 63 850
Diana Vara‐Ciruelos Spain 15 505 1.0× 157 1.1× 43 0.3× 59 0.7× 86 1.1× 18 814
T. R. Santhosh Kumar India 19 484 1.0× 99 0.7× 59 0.5× 51 0.6× 92 1.2× 40 992
Beiying Qiu Singapore 17 549 1.1× 82 0.6× 82 0.6× 45 0.5× 36 0.5× 32 883

Countries citing papers authored by Dilong Chen

Since Specialization
Citations

This map shows the geographic impact of Dilong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilong Chen more than expected).

Fields of papers citing papers by Dilong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilong Chen. The network helps show where Dilong Chen may publish in the future.

Co-authorship network of co-authors of Dilong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dilong Chen. A scholar is included among the top collaborators of Dilong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilong Chen. Dilong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Xiyang, Dilong Chen, Hua Yang, et al.. (2025). Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer. Frontiers in Pharmacology. 16. 1649314–1649314.
3.
Li, Xiaowei, Nannan Li, Dilong Chen, et al.. (2024). Ganoderic acids alleviate atherosclerosis by inhibiting macrophage M1 polarization via TLR4/MyD88/NF-κB signaling pathway. Atherosclerosis. 391. 117478–117478. 13 indexed citations
4.
Huang, Shiying, Yonghong Zhang, Hong Wang, et al.. (2024). Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway. Journal of Natural Medicines. 78(2). 342–354. 8 indexed citations
5.
Lin, Dongmei, Yukun Zhang, Hang Zhang, et al.. (2023). Ganoderma lucidum polysaccharide peptides GL-PPSQ2 alleviate intestinal ischemia-reperfusion injury via inhibiting cytotoxic neutrophil extracellular traps. International Journal of Biological Macromolecules. 244. 125370–125370. 26 indexed citations
7.
Wu, Mengna, Boyue Huang, Ling Hu, et al.. (2023). Ganoderma lucidum polysaccharides ameliorates D-galactose-induced aging salivary secretion disorders by upregulating the rhythm and aquaporins. Experimental Gerontology. 175. 112147–112147. 9 indexed citations
8.
Ran, Jianhua, et al.. (2022). Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing. Translational Cancer Research. 11(6). 1510–1522. 2 indexed citations
9.
Zhao, Shuang, Ke Xu, Rong Jiang, et al.. (2020). Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway. Life Sciences. 251. 117424–117424. 43 indexed citations
10.
Zhou, Peng, Xiaopeng Li, Rong Jiang, et al.. (2019). Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer. Anti-Cancer Drugs. 30(6). 611–617. 38 indexed citations
12.
Xiong, Wei, Haixing Li, Fen Wang, et al.. (2016). Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin. Oncology Reports. 36(4). 2059–2070. 34 indexed citations
13.
Li, Jing, Jing Xia, Rong Jiang, et al.. (2015). Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Chemico-Biological Interactions. 242. 227–234. 40 indexed citations
14.
Chen, Dilong, et al.. (2015). Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways. Asian Pacific Journal of Cancer Prevention. 16(8). 3509–3515. 14 indexed citations
15.
Zuo, Guowei, et al.. (2014). [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms].. PubMed. 34(7). 917–22. 1 indexed citations
16.
Zuo, Guowei, et al.. (2014). Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling. Asian Pacific Journal of Cancer Prevention. 15(18). 7849–7855. 12 indexed citations
17.
Li, Jing, Qiang Wei, Guowei Zuo, et al.. (2014). Ginsenoside Rg1 Induces Apoptosis through Inhibition of the EpoR-Mediated JAK2/STAT5 Signalling Pathway in the TF-1/Epo Human Leukemia Cell Line. Asian Pacific Journal of Cancer Prevention. 15(6). 2453–2459. 27 indexed citations
18.
Chen, Dilong. (2013). Effect of MAPK signal transduction pathway on apoptosis of leukemia K562 cells induced by ginseng polysaccharide. Zhongcaoyao.
19.
Liu, Yi, Dilong Chen, Rong Jiang, et al.. (2012). Mechanism of ginseng polysaccharide on apoptosis and cell cycle in leukemia K562 cells. 34(12). 1181–1184. 1 indexed citations
20.
Liu, Yonggang, Dilong Chen, Xuemei Lin, et al.. (2007). Leukemia Inhibitory Factor-Expressing Human Embryonic Lung Fibroblasts as Feeder Cells for Human Embryonic Germ Cells. Cells Tissues Organs. 186(4). 221–228. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026